{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:11:15Z","timestamp":1648825875143},"reference-count":48,"publisher":"Hogrefe Publishing Group","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Praxis"],"published-print":{"date-parts":[[2020,8]]},"abstract":" Zusammenfassung. In der Betreuung neurologischer Patienten mit Sch\u00e4digung des ersten Motoneurons, zum Beispiel nach Schlaganfall oder multipler Sklerose, ist Spastik ein h\u00e4ufiges Problem mit deutlicher Beeintr\u00e4chtigung der Lebensqualit\u00e4t. Die Behandlung basiert dabei in erster Linie auf therapeutischen und pflegerischen Massnahmen. Erg\u00e4nzend k\u00f6nnen in Abh\u00e4ngigkeit von der Verteilung der Spastik eine systemische antispastische Medikation oder eine lokale Behandlung mit Botulinumneurotoxin durchgef\u00fchrt werden. Bei unzureichendem Effekt k\u00f6nnen auch chirurgische Eingriffe in Betracht gezogen werden. <\/jats:p>","DOI":"10.1024\/1661-8157\/a003480","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T03:55:21Z","timestamp":1596599721000},"page":"794-800","source":"Crossref","is-referenced-by-count":0,"title":["Behandlung und Management der Spastik"],"prefix":"10.1024","volume":"109","author":[{"given":"Andreas","family":"Disko","sequence":"first","affiliation":[{"name":"Z\u00fcrcher RehaZentrum Lengg, Z\u00fcrich"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","reference":[{"key":"c1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182764c86"},{"key":"c2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182762448"},{"key":"c3","doi-asserted-by":"publisher","DOI":"10.1191\/1352458504ms1085oa"},{"key":"c4","first-page":"55","volume":"19","author":"Anson CA","year":"1996","journal-title":"Int J Rehabil Res Int Z Rehabil Rev Int Rech Readaptation"},{"key":"c5","volume-title":"Spasticity, disordered motor control","author":"Feldman RG","year":"1980"},{"key":"c6","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-199612000-00010"},{"key":"c7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.48.7.676"},{"key":"c8","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-0303"},{"key":"c9","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/67.2.206"},{"key":"c10","doi-asserted-by":"publisher","DOI":"10.3109\/09638288.2015.1014933"},{"key":"c11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.47.9.1029"},{"key":"c12","doi-asserted-by":"publisher","DOI":"10.1310\/tsr1503-177"},{"key":"c13","doi-asserted-by":"publisher","DOI":"10.1080\/09638280500534861"},{"key":"c14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmrj.2018.02.013"},{"key":"c15","doi-asserted-by":"publisher","DOI":"10.3109\/09638288.2014.946154"},{"key":"c16","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162206000685"},{"key":"c17","doi-asserted-by":"publisher","DOI":"10.12968\/ijtr.2007.14.3.23523"},{"key":"c18","doi-asserted-by":"crossref","unstructured":"Katalinic OM, Harvey LA, Herbert RD, Moseley AM, Lannin NA, Schurr K: Stretch for the treatment and prevention of contractures. In: The Cochrane Collaboration (Hrsg.). Cochrane Database of Systematic Reviews. Chichester, UK; Wiley: 2010. Verf\u00fcgbar unter: http:\/\/doi.wiley.com\/10.1002\/14651858.CD0074 55.pub2 ; letzter Zugriff: 24.03.2020.","DOI":"10.1002\/14651858.CD007455.pub2"},{"key":"c19","doi-asserted-by":"publisher","DOI":"10.1310\/Q0E8-0HEG-R6D4-D7V8"},{"key":"c20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.05.002"},{"key":"c21","first-page":"5","volume":"42","author":"Taricco M","year":"2006","journal-title":"Eur Medicophysica"},{"key":"c22","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte: Risikobewertungsverfahren. Tetrazepamhaltige Arzneimittel (z. B. Musaril\u00ae): Anordnung des Ruhens der Zulassungen im Rahmen der Umsetzung der Kommissionsentscheidung. Bonn; BfArM: 2019. https:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RV_STP\/s-z\/tetrazepam.html; letzter Zugriff: 24.03.2020."},{"key":"c23","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.089805"},{"key":"c24","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197713010-00002"},{"key":"c25","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9993(00)90135-7"},{"key":"c26","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.12.1772"},{"key":"c27","doi-asserted-by":"publisher","DOI":"10.3109\/02699052.2012.729285"},{"key":"c28","volume-title":"Cannabis und Cannabinoide: Pharmakologie, Toxikologie und therapeutisches Potenzial","author":"Grotenhermen F","year":"2004","edition":"2"},{"key":"c29","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314410"},{"key":"c30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707003"},{"key":"c31","doi-asserted-by":"publisher","DOI":"10.1159\/000112901"},{"key":"c32","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000363"},{"key":"c33","doi-asserted-by":"publisher","DOI":"10.1586\/ern.12.11"},{"key":"c34","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510367462"},{"key":"c35","first-page":"w 14463","volume":"147","author":"Kilcher G","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"c36","first-page":"9","volume":"5","author":"Belverud S","year":"2008","journal-title":"Intrathecal pumps"},{"key":"c37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91487-9"},{"key":"c38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198906083202303"},{"key":"c39","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1396012"},{"key":"c40","doi-asserted-by":"publisher","DOI":"10.1177\/1545968310363585"},{"key":"c41","doi-asserted-by":"crossref","unstructured":"Schramm A, Ndayisaba J-P, auf dem Brinke\n M, et al.: Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry. J Neural Transm [Internet] 2014 [zitiert 24. August 2019]; Verf\u00fcgbar unter: http:\/\/link.springer.com\/10.1007\/s00702-013-1145-3; letzter Zugriff: 18.03.2020.","DOI":"10.1007\/s00702-013-1145-3"},{"key":"c42","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2015.05.002"},{"key":"c43","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2006.02.015"},{"key":"c44","first-page":"1","volume":"21","author":"Park TS","year":"2006","journal-title":"Neurosurg Focus"},{"key":"c45","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-007-0383-9"},{"key":"c46","doi-asserted-by":"publisher","DOI":"10.1080\/09638280010029930"},{"key":"c47","doi-asserted-by":"publisher","DOI":"10.1177\/026921559601000108"},{"key":"c48","unstructured":"Panakeia.ch: Vergleichstabelle. https:\/\/panakeia.ch\/fileadmin\/ user_upload\/Downloads\/Cannabis\/2018_Vergleichstabelle_Dronabinol_Cannabistinktur_Cannabisoel.pdf; letzter Zugriff: 18.03.2020."}],"container-title":["Praxis"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/1661-8157\/a003480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T23:31:29Z","timestamp":1615937489000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/1661-8157\/a003480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1024\/1661-8157\/a003480"],"URL":"https:\/\/doi.org\/10.1024\/1661-8157\/a003480","relation":{},"ISSN":["1661-8157","1661-8165"],"issn-type":[{"value":"1661-8157","type":"print"},{"value":"1661-8165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}